Page last updated: 2024-08-21

dicyclohexylcarbodiimide and Papilloma, Squamous Cell

dicyclohexylcarbodiimide has been researched along with Papilloma, Squamous Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies

Other Studies

1 other study(ies) available for dicyclohexylcarbodiimide and Papilloma, Squamous Cell

Article	Year
NTP report on the toxicology studies of dicyclohexylcarbodiimide (CAS No. 538-75-0) in F344/N rats, B6C3F 1 mice, and genetically modified (FVB Tg.AC hemizygous) mice and carcinogenicity study of dicyclohexylcarbodiimide in genetically modified [B6.129-Tr National Toxicology Program genetically modified model report, 2007, Issue:9 Topics: Administration, Cutaneous; Animals; Carcinogenicity Tests; Carcinogens; Dicyclohexylcarbodiimide; Female; Genes, ras; Hyperplasia; Inflammation; Mice; Mice, Transgenic; Papilloma; Rats; Rats, Inbred F344; Skin Neoplasms; Tumor Suppressor Protein p53	2007

Article

Year

NTP report on the toxicology studies of dicyclohexylcarbodiimide (CAS No. 538-75-0) in F344/N rats, B6C3F 1 mice, and genetically modified (FVB Tg.AC hemizygous) mice and carcinogenicity study of dicyclohexylcarbodiimide in genetically modified [B6.129-Tr

National Toxicology Program genetically modified model report, 2007, Issue:9

Topics: Administration, Cutaneous; Animals; Carcinogenicity Tests; Carcinogens; Dicyclohexylcarbodiimide; Female; Genes, ras; Hyperplasia; Inflammation; Mice; Mice, Transgenic; Papilloma; Rats; Rats, Inbred F344; Skin Neoplasms; Tumor Suppressor Protein p53

2007